← Back to Search

Topical Agent

Liftactiv B3 for Acne

Phase 2
Waitlist Available
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month, 2 months, and 3 months
Awards & highlights

Study Summary

This trial is testing a serum to see if it can help with PIHP, a condition that causes brown patches on the face.

Eligible Conditions
  • Acne
  • Postinflammatory Hyperpigmentation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month, 2 months, and 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month, 2 months, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post Inflammatory Hyperpigmentation (PIHP) Change
Secondary outcome measures
Change in Cosmeticity Questionnaire and Acceptability
Change in Global Efficacy Assessment
Change in Global Tolerance Score
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Liftactiv B3Experimental Treatment1 Intervention
Participants will undergo a wash out phase of two weeks where they regularly apply a moisturizer (Hydreane Legere) in the morning and a sunscreen in the morning and at the beginning of the afternoon. On the 3rd week, participants will apply Liftactiv B3 serum daily in the morning before sunscreen and in the evening (two applications daily) on half face for 3 months.
Group II: Control GroupActive Control1 Intervention
Participant will receive sunscreen in the morning and at the beginning of the afternoon for 3 months.

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
898 Previous Clinical Trials
409,638 Total Patients Enrolled
1 Trials studying Acne
14 Patients Enrolled for Acne
Vichy LaboratoiresIndustry Sponsor
1 Previous Clinical Trials
200 Total Patients Enrolled
1 Trials studying Acne
200 Patients Enrolled for Acne

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research program accept volunteers?

"To qualify for this study, prospective participants must be between 18 and 50 years old with a diagnosis of acne. A total of 30 people are needed to participate in the trial."

Answered by AI

What is the size of this research population?

"Affirmative. Clinicaltrials.gov data indicates that this trial, which was first made available on March 22nd 2022, is actively recruiting participants. 30 individuals need to be recruited from a single medical centre."

Answered by AI

How secure is Liftactiv B3 for consumers?

"Based on the data available, Liftactiv B3 received a score of 2 as this is currently in its Phase 2 which suggests some evidence of safety but no indication of efficacy."

Answered by AI

Is this experiment actively seeking participants?

"Correct. Per clinicaltrials.gov, this experiment has commenced participant recruitment since March 22nd 2022 and is now searching for 30 individuals across one site. Its details were last updated on November 4th 2022."

Answered by AI

Is the age eligibility for this trial restricted to those under 25 years of age?

"All subjects that are eligible for this medical trial must be between 18 and 50 years old."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)
Leigh Nattkemper 2022. "LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05327361.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top